134 related articles for article (PubMed ID: 23328932)
1. Nuclear factor-κB activation in primary lymphoma of bone.
Koens L; Heyning FH; Szepesi A; Matolcsy A; Hogendoorn PC; Jansen PM
Virchows Arch; 2013 Mar; 462(3):349-54. PubMed ID: 23328932
[TBL] [Abstract][Full Text] [Related]
2. Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Sierra J; Prat J
Histopathology; 2008 Oct; 53(4):441-9. PubMed ID: 18983609
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological implications of nuclear factor κB signal pathway activation in diffuse large B-cell lymphoma.
Zhao Q; Fu W; Jiang H; Du J; Zhang C; Xi H; Zhou F; Li R; Hou J
Hum Pathol; 2015 Apr; 46(4):524-31. PubMed ID: 25636172
[TBL] [Abstract][Full Text] [Related]
5. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.
Montes-Moreno S; Odqvist L; Diaz-Perez JA; Lopez AB; de Villambrosía SG; Mazorra F; Castillo ME; Lopez M; Pajares R; García JF; Mollejo M; Camacho FI; Ruiz-Marcellán C; Adrados M; Ortiz N; Franco R; Ortiz-Hidalgo C; Suarez-Gauthier A; Young KH; Piris MA
Mod Pathol; 2012 Jul; 25(7):968-82. PubMed ID: 22538516
[TBL] [Abstract][Full Text] [Related]
6. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.
Shin HC; Seo J; Kang BW; Moon JH; Chae YS; Lee SJ; Lee YJ; Han S; Seo SK; Kim JG; Sohn SK; Park TI
Korean J Intern Med; 2014 Nov; 29(6):785-92. PubMed ID: 25378977
[TBL] [Abstract][Full Text] [Related]
8. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
[TBL] [Abstract][Full Text] [Related]
9. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
Quesada AE; Nguyen ND; Rios A; Brown RE
Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
[TBL] [Abstract][Full Text] [Related]
10. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
11. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
12. Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype.
Heyning FH; Hogendoorn PC; Kramer MH; Holland CT; Dreef E; Jansen PM
J Clin Pathol; 2009 Sep; 62(9):820-4. PubMed ID: 19734480
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
14. Frequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Noujima-Harada M; Takata K; Miyata-Takata T; Sakurai H; Igarashi K; Ito E; Nagakita K; Taniguchi K; Ohnishi N; Omote S; Tabata T; Sato Y; Yoshino T
Cancer Sci; 2017 May; 108(5):1071-1079. PubMed ID: 28256087
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
[TBL] [Abstract][Full Text] [Related]
16. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
[TBL] [Abstract][Full Text] [Related]
17. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
18. [PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS].
Škunca Z; Planinc-Peraica A
Acta Med Croatica; 2015 Mar; 69(1):25-32. PubMed ID: 26606782
[TBL] [Abstract][Full Text] [Related]
19. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.
Puvvada SD; Funkhouser WK; Greene K; Deal A; Chu H; Baldwin AS; Tepper JE; O'Neil BH
Oncology; 2010; 78(3-4):181-8. PubMed ID: 20414006
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X
Hum Pathol; 2008 Jul; 39(7):994-1001. PubMed ID: 18508109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]